InMed Pharmaceuticals Positioned For Growth As Cannabinoid Supply Sales Poised For Imminent “Take Off” Sep 22, 2021
Tryp Therapeutics Submits IND Application For Phase 2a Clinical Trial In Eating Disorders Sep 22, 2021
NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr.… Sep 22, 2021
SLANG Worldwide CEO Chris Driessen: Industry Growth Will Continue, With Or Without Federal Regulations Sep 21, 2021
